KFDA to strengthen on-spot inspection

Published: 2010-07-02 06:59:00

Updated: 2010-07-02 06:59:00

The Korea Food and Drug Administration plans to undertake its on-spot inspection on the manufacturing facilities of imported drugs overseas in a bid to prevent the importation of any sub-substandard products.

To this end, KFDA investigators will check the quality control and manufacturing pro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK